IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Nab-Paclitaxel
Sponsor: Barwon Health